Multicenter, Dose-Finding Safety and Activity Study of AMD11070 in HIV-Infected Patients Carrying X4-Tropic Virus.
Phase of Trial: Phase I/II
Latest Information Update: 24 Aug 2013
At a glance
- Drugs AMD 070 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms XACT
- Sponsors AnorMED; Genzyme Corporation
- 07 Jun 2017 Biomarkers information updated
- 08 Sep 2010 Actual end date (October 2005) added as reported by ClinicalTrials.gov.
- 08 Sep 2010 Status changed from suspended to completed as reported by ClinicalTrials.gov.